<DOC>
	<DOCNO>NCT00696709</DOCNO>
	<brief_summary>The purpose study see investigational vaccine shingle safe well tolerate brings acceptable antibody response .</brief_summary>
	<brief_title>A Study Test Safety Antibody Response V212 Healthy Adults ( V212-004 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Must 50 59 year age No fever vaccination day Must chickenpox live area chickenpox virus prevalent 30 year Females childbearing potential must use acceptable form birth control Prior history shingle Prior receipt chickenpox shingle vaccine Pregnant breastfeeding Received expect receive live virus vaccine ( measles , mumps , rubella ) 4 week first visit last visit Received expect receive inactivate vaccine ( tetanus pneumonia ) 7 day first visit last visit Received immunoglobulin blood product Receiving treatment may weaken immune system Have immune system disorder</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Herpes Zoster ( Shingles )</keyword>
</DOC>